ReviewBioengineering (Basel, Switzerland)2026
Diffusion Magnetic Resonance Imaging Models for Detecting Brain Microstructural Abnormalities in Type 2 Diabetes: A Systematic Review.
Review in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The global prevalence of type 2 diabetes mellitus (T2DM) has increased more than twofold over the last thirty years. T2DM is associated with multiple complications, among which diabetic encephalopathy and accompanying cognitive impairment have drawn considerable interest. This systematic review synthesizes findings from advanced diffusion magnetic resonance imaging (dMRI) studies (published from 2009 to 2025) on T2DM-related brain microstructural abnormalities. The most common technique, diffusion tensor imaging (DTI), consistently reveals reduced white-matter integrity (lower fractional anisotropy, higher diffusivity) associated with cognitive impairment. DTI-based network analysis further identifies disrupted structural network topology, characterized by reduced global and nodal efficiency. To overcome DTI's limitations, newer techniques provide more specific insights: diffusion kurtosis imaging shows reduced tissue complexity in white matter, gray matter, and crossing-fiber regions via non-Gaussian modeling; neurite orientation dispersion and density imaging quantifies decreased neurite density; intravoxel incoherent motion assesses combined microstructural and microvascular alterations; diffusion spectrum imaging maps complex fiber architecture. These dMRI metrics may provide promising imaging markers for characterizing T2DM-related brain microstructural alterations. However, most available evidence remains cross-sectional, and further longitudinal, multicenter validation is required before these measures can be considered clinically validated biomarkers for prediction, diagnosis, or monitoring.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.